Characterization of the individual capacity for repair of genotoxic damage of a Bulgarian hESC line and two commonly used stabilized cell lines

References

• Kobold S, Guhr A, Kurtz A, et al. Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field. Stem Cell Reports. 2015;4(5):914–925.
   PubMed Web of Science ®Google Scholar
• Seltmann S, Lekschas F, Müller R, et al. hPSCreg–the human pluripotent stem cell registry. Nucleic Acids Res. 2016;44(D1):D757–763.
   PubMed Web of Science ®Google Scholar
• Kobold S, Guhr A, Mah N, et al. A manually curated database on clinical studies involving cell products derived from human pluripotent stem cells. Stem Cell Reports. 2020;15(2):546–555.
   PubMed Web of Science ®Google Scholar
• Petkova R, Zhelev N, Pankov R, et al. Individual capacity for repair of DNA damage and potential uses of stem cell lines for clinical applications: a matter of (genomic) integrity. Biotechnol Biotechnol Equip. 2018;32(6):1352–1358.
   Web of Science ®Google Scholar
• Ben M'Barek K, Bertin S, Brazhnikova E, et al. Clinical-grade production and safe delivery of human ESC derived RPE sheets in primates and rodents. Biomaterials. 2020;230:119603.
   PubMed Web of Science ®Google Scholar
• Rehakova D, Souralova D, Koutna I. Clinical-grade human pluripotent stem cells for cell therapy: characterization strategy. IJMS. 2020;21(7):2435.
   Google Scholar
• Tilgner K, Neganova I, Moreno-Gimeno I, et al. A human iPSC model of ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. Cell Death Differ. 2013;20(8):1089–1100.
   PubMed Web of Science ®Google Scholar
• Hare I, Gencheva M, Evans R, et al. In vitro expansion of bone marrow derived mesenchymal stem cells alters DNA double strand break repair of etoposide induced DNA damage. Stem Cells Int. 2016;2016:8270464.
   PubMed Web of Science ®Google Scholar
• Gant VU, Junco JJ, Terrell M, et al. Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both down syndrome and non-Down syndrome genetic backgrounds. PLoS One. 2021;16(1):e0244863. DOI: 10.1371/journal.pone.0244863
   PubMed Web of Science ®Google Scholar
• Rogers JH, Gupta R, Reyes JM, et al. Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities. Blood Adv. 2021;5(19):3876–3890.
   PubMed Web of Science ®Google Scholar
• Simara P, Tesarova L, Rehakova D, et al. DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing. Stem Cell Res Ther. 2017;8(1):73.
   PubMedGoogle Scholar
• di Val Cervo PR, Besusso D, Conforti P, et al. hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible. Nat Rev Neurol. 2021;17(6):381–392.
   PubMed Web of Science ®Google Scholar
• Al-Khalaf MH, Blake LE, Larsen BD, et al. Temporal activation of XRCC1-mediated DNA repair is essential for muscle differentiation. Cell Discov. 2016;2:15041.
   PubMed Web of Science ®Google Scholar
• Regent F, Morizur L, Lesueur L, et al. Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions. Sci Rep. 2019;9(1):10646.
   PubMedGoogle Scholar
• Reynolds L. The success of stem cell transplantations and the potential post-transplantation complications may be dependent, among other factors, on the capacity of the recipient and the transplanted cells to repair DNA damage. BD. 2016;19:e9076.
   Google Scholar
• Khalil HS, Petkova R, Zhelev N. Differential genetic advantages in youth and in aging, or how to die healthy. Biotechnol Biotechnol Equip. 2012;26(1):2703–2711.
   Web of Science ®Google Scholar
• Chelenkova P, Petkova R, Chamova T, et al. The fine art of vascular wall maintenance. Carriership of XPC, TP53 and APOE polymorphisms may be a risk factor for cerebral vascular accidents in the Bulgarian population. Biotechnol Biotechnol Equip. 2018;32(6):1558–1566.
   Web of Science ®Google Scholar
• Petkova R, Chelenkova P, Georgieva E, et al. What’s your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part I—role of individual repair capacity in the constitution of risk for late-onset multifactorial disease. Biotechnol Biotechnol Equip. 2013;27(6):4208–4216.
   Web of Science ®Google Scholar
• Arabadjiev B, Petkova R, Nonchev S, et al. Derivation of human embryonic stem cell line from discarded IVF morula. Compt Rend Bulg Acad Sci. 2010;63(12):1765–1770.
   Web of Science ®Google Scholar
• Foley GE, Lazarus H, Farber S, et al. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 1965;18(4):522–529.
   PubMed Web of Science ®Google Scholar
• Schneider U, Schwenk H, Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukaemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer. 1977;19(5):621–626.
   PubMed Web of Science ®Google Scholar
• Krüger S, Bier A, Engel C, German Hereditary Non-Polyposis Colorectal Cancer Consortium, et al. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC). J Med Genet. 2005;42(10):769–773.
   PubMed Web of Science ®Google Scholar
• Khan SG, Metter EJ, Tarone RE, et al. A new xeroderma pigmentosum group C poly(at) insertion/deletion polymorphism. Carcinogenesis. 2000;21(10):1821–1825.
   PubMed Web of Science ®Google Scholar
• Chen P, Wiencke J, Aldape K, et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev. 2000;9(8):843–847.
   PubMed Web of Science ®Google Scholar
• López-Cima MF, González-Arriaga P, García-Castro L, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain. BMC Cancer. 2007;7:162.
   PubMed Web of Science ®Google Scholar
• Schmitz C, Lindpaintner K, Verhoef P, et al. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation. 1996;94(8):1812–1814.
   PubMedGoogle Scholar
• Tan SM, Wang ST, Hentze H, et al. A UTF1-based selection system for stable homogeneously pluripotent human embryonic stem cell cultures. Nucleic Acids Res. 2007;35(18):e118.
   PubMed Web of Science ®Google Scholar
• Seigel GM, Hackam AS, Ganguly A, et al. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007;13:823–832.
   PubMed Web of Science ®Google Scholar
• Klijn C, Durinck S, Stawiski EW, et al. A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol. 2015;33(3):306–312.
   PubMed Web of Science ®Google Scholar
• Laumann R, Jücker M, Tesch H. Point mutations in the conserved regions of the p53 tumour suppressor gene do not account for the transforming process in the jurkat acute lymphoblastic leukemia T-cells. Leukemia. 1992;6(3):227–228.
   PubMed Web of Science ®Google Scholar
• Rafki N, Liautaud-Roger F, Devy L, et al. P53 protein expression in human multidrug-resistant CEM lymphoblasts. Leuk Res. 1997;21(2):147–152.
   PubMed Web of Science ®Google Scholar
• Nelson HH, Wilkojmen M, Marsit CJ, et al. TP53 mutation, allelism and survival in non-small cell lung cancer. Carcinogenesis. 2005;26(10):1770–1773.
   PubMed Web of Science ®Google Scholar
• Marín MS, López-Cima MF, García-Castro L, et al. Poly (at) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(11 Pt 1):1788–1793.
   PubMed Web of Science ®Google Scholar
• Dai QS, Hua RX, Zhang R, et al. Poly (at) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis. Gene. 2013;528(2):335–342.
   PubMed Web of Science ®Google Scholar
• Wu H, Li S, Hu X, et al. Associations of mRNA expression of DNA repair genes and genetic polymorphisms with cancer risk: a bioinformatics analysis and Meta-analysis. J Cancer. 2019;10(16):3593–3607.
   PubMed Web of Science ®Google Scholar
• Zhuo Z, Miao L, Hua W, et al. He J genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility. Int J Cancer. 2021;149(9):1649–1658.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yang H, Chen Q, et al. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. DNA Repair (Amst). 2008;7(2):141–148.
   PubMed Web of Science ®Google Scholar
• Woelfelschneider A, Popanda O, Lilla C, et al. A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients. Carcinogenesis. 2008;29(9):1758–1764.
   PubMed Web of Science ®Google Scholar
• Sturgis EM, Dahlstrom KR, Spitz MR, et al. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2002;128(9):1084–1088.
   PubMedGoogle Scholar
• Yin Z, Zhou B, He Q, et al. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC Cancer. 2009;9(1):439.
   PubMedGoogle Scholar
• Skjelbred CF, Saebø M, Wallin H, et al. Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a norwegian cohort: a case control study. BMC Cancer. 2006;6:67.
   PubMed Web of Science ®Google Scholar
• Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25(5):757–763.
   PubMed Web of Science ®Google Scholar
• Chai F, Liang Y, Chen L, et al. Association between XRCC3 Thr241Met polymorphism and risk of breast cancer: meta-analysis of 23 case-control studies. Med Sci Monit. 2015;21:3231–3240.
   PubMed Web of Science ®Google Scholar
• Michalska MM, Samulak D, Romanowicz H, et al. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in polish women. Exp Mol Pathol. 2016;100(2):243–247.
   PubMed Web of Science ®Google Scholar
• Avci H, Ergen A, Bireller ES, et al. A strong relationship between oral squamous cell carcinoma and DNA repair genes. Biochem Genet. 2017;55(5–6):378–386.
   PubMed Web of Science ®Google Scholar
• Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C > T allele of 5,10 ethylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet. 2003;40(8):619–625.
   PubMed Web of Science ®Google Scholar
• Petrone I, Bernardo PS, Dos Santos EC, et al. MTHFR C677T and A1298C polymorphisms in breast cancer, gliomas and gastric cancer: a review. Genes (Basel). 2021;12(4):587.
   PubMed Web of Science ®Google Scholar
• Arancibia T, Morales-Pison S, Maldonado E, et al. Association between single-nucleotide polymorphisms in miRNA and breast cancer risk: an updated review. Biol Res. 2021;54(1):26.
   PubMed Web of Science ®Google Scholar
• Chicheva Z, Chelenkova P, Petkova R, et al. Children of the sun, children of the moon—a mini-panel for assessment of inter-individual variation between the capacity of healthy individuals to repair everyday genotoxic insults. Biotechnol Biotechnol Equip. 2012;26(4):3142–3147.
   Web of Science ®Google Scholar
• Chelenkova P, Petkova R, Chamova T, et al. Homozygous carriership of the wildtype allele of the XPCins83 polymorphism is an independent protective factor against cerebrovascular incidents in the bulgarian population. Compt Rend Acad Bulg Sci. 2014;67(2):263–268.
   Web of Science ®Google Scholar
• Abbasalizadeh S, Baharvand H. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies. Biotechnol Adv. 2013;31(8):1600–1623.
   PubMed Web of Science ®Google Scholar
• Sverdlov ED, Mineev K. Mutation rate in stem cells: an underestimated barrier on the way to therapy. Trends Mol Med. 2013;19(5):273–280.
   PubMed Web of Science ®Google Scholar